You are here
Biomedical Science and Biochemistry Seminar Series
Seminars from the RSB Division of Biomedical Science and Biochemistry.
18
Jul
2024
1–2pm 18 July 2024
Imam Fathoni, PhD Candidate, Saliba Group
Malaria is a significant disease in Africa, certain countries in Asia, and Central and South America. In 2022, malaria infected approximately 233 million people and caused 608,000 death.
BSB PhD Exit Seminar: Targeting Thiamine (Vitamin B1) Metabolism and Utilisation in Plasmodium
Malaria is a significant disease in Africa, certain countries in Asia, and Central and South America. In 2022, malaria infected approximately 233 million people and caused 608,000 death.. More information here: https://biology.anu.edu.au/news-events/events/bsb-phd-exit-seminar-targeting-thiamine-vitamin-b1-metabolism-and-utilisation
2024-07-18 03:00:00 to 2024-07-18 04:00:00Z
2024-07-18 03:00:00 to 2024-07-18 04:00:00Z
Please note: this seminar is only available via Zoom.
Please click the link below to join the webinar:
https://anu.zoom.us/j/83820172420?pwd=RtVlaYGaznGhYh1D5mmyOV8a3zK1sE.1
Webinar ID: 838 2017 2420
Passcode: 168103
Canberra time: please check your local time & date if you are watching from elsewhere.
Past events
04
Apr
2024
BSB Seminar Series: My life with membrane proteins: taming membrane transporters »
A lipid bilayer is a vital component of the cell. It is selectively permeable, allowing only ions and organic molecules to pass through. Ions and solutes are transported by membrane transporters. Dysfunction of such proteins can lead to physiological disorders.
28
Mar
2024
BSB Seminar Series: RSB Precision Fermentation Facility »
Discover the capabilities of the new Precision Fermentation Facility that has been established at RSB, including an overview of the equipment, its capabilities and potential applications.
15
Feb
2024
BSB Seminar Series: Discovery and characterization of JNT-517, a first-in-class inhibitor of SLC6A19 for the treatment of phenylketonuria »
Toxic accumulation of phenylalanine underlies the neurological deficits and morbidity in phenylketonuria (PKU). Despite availability of treatment options for PKU patients, high unmet need remains for safe and convenient therapies that work across a broad cross section of PKU patients and allow for diet normalization.
15
Dec
2023
BSB PhD Exit Seminar: Cellular and molecular characterisation of regeneration in calcareous sponges and corals »
Regeneration is the natural ability to restore or replace damaged or lost body parts following severe injury. Regenerative abilities vary strongly across and within most bilaterian phyla.
17
Nov
2023
BSB Seminar Series: Room temperature DNA storage to enhanced Drug bioavailability: Magic molecules Ionic Liquids in action »
DNA stability is a prerequisite in many of its applications, ranging from DNA-based vaccine, data storage to gene therapy. However, the existing strategies to enhance the DNA stability are ineffective and limited in scope.
14
Nov
2023
Joint PS and BSB Seminar - Synthetic control of peptide and protein architectures »
Synthetic chemistry and synthetic biology offer complementary tools for manipulating the 3D architecture and function of biomolecules. I will outline two different projects that exemplify our hybrid chemical biology approach, highlighting divergent applications in catalysis and cancer therapy.
02
Nov
2023
BSB Seminar Series: Malaria parasite invasion of human red blood cells and the insights we can obtain from 4D imaging »
Associate Professor Kelly Roger's team has built a lattice light sheet microscope which was instrumental in the discovery that mitochondrial DNA is released during apoptosis through BAK and BAX pores in the outer mitochondrial membrane.
11
Sep
2023
BSB Seminar: A chemogenetics platform for antimalarial drug target identification and hit discovery »
Malaria is a major global health problem, with 247 million cases and 619,000 deaths estimated in 2021. Antimalarial drugs are critical for malaria treatment and eradication efforts.
20
Jul
2023
BSB Seminar: Development and characterisation of novel antimalarial chemotypes from the Janssen Jumpstarter library »
Malaria is a devastating disease caused by the Plasmodium parasite. Due to the threat of emerging drug resistance, the current arsenal of clinically used artemisinin combination therapies and drug candidates undergoing clinical assessment may not be sufficient in eliminating the disease.
06
Jul
2023
BSB Seminar: Deconstructing Solid Tumour Heterogeneity: The Matrix Perspective »
Homeostasis of the extracellular matrix is critical for correct organ and tissue function. Both the biochemical and biomechanical properties of the matrix contribute to modulating the behaviour of resident cells and are more than just passive bystanders.
22
Jun
2023
BSB Seminar: Membranes under the lens: Using structural biology data to visualise receptor dynamics »
How can we tell engaging stories about complex biological processes that are invisible to the naked eye?
Scientists utilise a variety of techniques to investigate and visualise membrane receptors (gatekeepers of information) that transfer signals across membranes.
08
Jun
2023
BSB PhD Exit Seminar: Investigating the potential for P-glycoprotein in the prevention of Alzheimer’s Disease »
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterised by the deposition of Amyloid-β (Aβ) aggregates throughout the cerebrum, especially in the cerebrovascular and hippocampal tissues.
01
Jun
2023
BSB PhD Exit Seminar: Structural and functional characterisation of MlaD from Acinetobacter baumannii »
Acinetobacter baumannii (Ab) is a clinically important pathogen that has rapidly developed resistance to many antimicrobials.
25
May
2023
BSB PhD Exit Seminar: The loopy nature of autotransporter passenger domain folding »
Autotransporters are a large family of bacterial secreted and/or outer membrane proteins that play key roles in the pathogenesis of many infectious diseases.
18
May
2023
BSB PhD Exit Seminar: Peeling back some layers of ABCA4 – ways to study it and insights into its function »
Mutations in the gene encoding the human ATP-binding Cassette (ABC) transporter ABCA4 are implicated in several visual disorders including Stargardt’s disease, an early onset macular dystrophy.